Occidental Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Occidental Asset Management, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $43.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$43.3M
| Company | Shares | Value |
|---|---|---|
| CORCencora Inc. | 19,357 | $6.1M |
| AMGNAMGEN INC | 16,786 | $5.9M |
| CAHCardinal Health Inc. | 27,759 | $5.9M |
| MRKMerck & Co., Inc. | 45,775 | $5.5M |
| DGXQuest Diagnostics Incorporated | 27,692 | $5.4M |
| GILDGILEAD SCIENCES, INC. | 33,376 | $4.7M |
| ABBVAbbVie Inc. | 11,067 | $2.4M |
| LLYELI LILLY & Co | 2,189 | $2.0M |
| PMPhilip Morris International Inc | 6,712 | $1.1M |
| JNJJOHNSON & JOHNSON | 4,146 | $1.0M |
| ABTABBOTT LABORATORIES | 6,312 | $648K |
| BMYBRISTOL MYERS SQUIBB CO | 8,230 | $499K |
| NVSNovartis AG | 3,189 | $487K |
| MCKMcKesson Corporation | 507 | $439K |
| TGTXTG THERAPEUTICS, INC. | 12,040 | $400K |
| AZNASTRAZENECA PLC | 1,603 | $316K |
| PFEPFIZER INC | 9,853 | $277K |
| HALOHALOZYME THERAPEUTICS, INC. | 3,659 | $236K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.